These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36387103)

  • 1. Affinity probes based on small-molecule inhibitors for tumor imaging.
    Yi X; Wang Z; Hu X; Yu A
    Front Oncol; 2022; 12():1028493. PubMed ID: 36387103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing the bioavailability of small molecular optical imaging probes by conjugation to an albumin affinity tag.
    Hahnenkamp A; Alsibai W; Bremer C; Höltke C
    J Control Release; 2014 Jul; 186():32-40. PubMed ID: 24815420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
    Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
    Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical in vivo cancer, straightway to patients?
    de Jong M; Mather S; Maina T
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):145-152. PubMed ID: 28347131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Imaging of Triple-Negative Breast Cancer Cells in Xenograft Athymic Mice Using an ICAM-1-Targeting Small-Molecule Probe.
    Zhang Y; Wang M; Liu W; Peng X
    Mol Imaging Biol; 2019 Oct; 21(5):835-841. PubMed ID: 30623283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties.
    Kossatz S; Mansi R; Béhé M; Czerney P; Hilger I
    EJNMMI Res; 2013 Nov; 3(1):75. PubMed ID: 24238262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Based on lapatinib innovative near-infrared fluorescent probes targeting HER1/HER2 for in vivo tumors imaging.
    Li C; Lin Q; Hu F; Bao R; Cai H; Gu Y
    Biosens Bioelectron; 2022 Oct; 214():114503. PubMed ID: 35779413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications.
    Kobayashi H; Choyke PL
    Acc Chem Res; 2011 Feb; 44(2):83-90. PubMed ID: 21062101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifaceted roles of peptides in "always-on" near-infrared fluorescent probes for tumor imaging.
    Xu H; Wang H; Xu Z; Bian S; Xu Z; Zhang H
    Bioorg Chem; 2022 Dec; 129():106182. PubMed ID: 36341739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acoustogenic Probes: A New Frontier in Photoacoustic Imaging.
    Knox HJ; Chan J
    Acc Chem Res; 2018 Nov; 51(11):2897-2905. PubMed ID: 30379532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of organic fluorescent probe-assisted near infrared fluorescence imaging in cervical cancer diagnosis].
    Zhu L; Zhang L; Zhou M; Alifu N
    Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2678-2687. PubMed ID: 34472288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule probes from bench to bedside: advancing molecular analysis of drug-target interactions toward precision medicine.
    Pan S; Ding A; Li Y; Sun Y; Zhan Y; Ye Z; Song N; Peng B; Li L; Huang W; Shao H
    Chem Soc Rev; 2023 Aug; 52(16):5706-5743. PubMed ID: 37525607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
    Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M
    J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.